These results also demonstrated that in the three groups, GC patient prognosis was negatively correlated with increased incidence of mutated TP53 and positively correlated with increased mutations in TTN and MUC16. Meanwhile, word clouds were drawn with the size of scripts reflecting the numbers of mutant genes in the samples (Figure 3B). This evidence concerns the gene TP53 and gastric cancer.